The GLP-1 Arms Race, Explained In the realm of pharmaceuticals, the race to develop the next groundbreaking weight-loss drug has intensified in recent years. Companies like Novo Nordisk and Eli Lilly have long been key players in this arena, with their development of GLP-1 receptor agonists – a type of drug that helps regulate insulin, […]
Eli Lilly Rolls Out Its GLP-1 Strategy Worldwide
Eli Lilly Rolls Out Its GLP-1 Strategy Worldwide Eli Lilly, a renowned pharmaceutical company, is making waves with its ambitious plans to expand its GLP-1 strategy globally. By teaming up with telehealth firms and e-commerce platforms, the company aims to mirror its success in the United States on an international scale. Lilly’s international president recently […]
Serena Williams Fronts Campaign for Weight Loss Drugs
Serena Williams Fronts Campaign for Weight Loss Drugs Telehealth company Ro has made waves in the health industry with its latest campaign featuring none other than tennis legend Serena Williams. The focus of this groundbreaking campaign? Weight loss, a topic that Serena is intimately familiar with as she shares her journey of using a monthly […]
Wellness Wants In on the Ozempiconomy
In recent months, a remarkable trend has emerged within the wellness sector, closely following the pharmaceutical industry’s innovations. The spotlight is on GLP-1 receptor agonists, hormones that have gained notoriety due to their association with popular weight loss drugs like Ozempic and Wegovy. As wellness brands jostle to stake their claim in this burgeoning field, […]